Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
The efficacy and safety of the external artificial pancreas during exercise of different intensities in adults with type 1 diabetes mellitus.
FY 2014-15
Summary
Type 1 diabetes (T1D) is an autoimmune disease that destroys the insulin producing Beta-cells of the pancreas. Currently, T1D is treated with multiple daily insulin injections or insulin infusion pumps. High glucose (sugar) must be controlled to prevent and slow the progression of the complications of diabetes such as heart disease, blindness and kidney failure. Unfortunately, more than half of the patients fail to achieve a good glucose control with the fear of insulin-induced hypoglycemia (low blood sugar) being the main barrier. For example, exercise, which is highly recommended in T1D, is often avoided because it can induce hypoglycemia. New advances in technology led to the development of the closed-loop system, or the so called external artificial pancreas. The system is composed of 3 components: continuous glucose sensor (to constantly read blood glucose changes), infusion pumps (to provide insulin with or without glucagon the main hormone to raise blood glucose) and an intelligent dosing software that modify pump infusions based on the sensor readings. Our 9 ongoing or completed trials have shown that the artificial pancreas improves both high and low blood glucose values, for example a 4 to 8-fold hypoglycemic risk reduction. Specifically, the aim of this study is to test the efficacy of the system to prevent exercise induce hypoglycemia in adults with T1D.
Two types of exercise will be tested continuous with moderate intensity and interval with high intensity. The metabolism of glucose by the body will also be studied during the different interventions. The results will help to improve the performance of the artificial pancreas and to guide long term trials under free living conditions planned to start in the next year.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331495
Name
Taleb Nadine M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The efficacy and safety of the external artificial pancreas during exercise of different intensities in adults with type 1 diabetes mellitus.
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Continuous Glucose Monitoring System; Diabetes Mellitus Type1; External Artificial Pancreas; Glucagon Pump; Glucose Kinetics; High Intensity Interval Exercise; Hypoglycemia; Insulin Pump; Moderate Intensity Continuous Exercise; Stable Isotope Tracer
Abstract
Type 1 diabetes (T1D) is an autoimmune disease that destroys the insulin producing Beta-cells of the pancreas. Currently, T1D is treated with multiple daily insulin injections or insulin infusion pumps. High glucose (sugar) must be controlled to prevent and slow the progression of the complications of diabetes such as heart disease, blindness and kidney failure. Unfortunately, more than half of the patients fail to achieve a good glucose control with the fear of insulin-induced hypoglycemia (low blood sugar) being the main barrier. For example, exercise, which is highly recommended in T1D, is often avoided because it can induce hypoglycemia. New advances in technology led to the development of the closed-loop system, or the so called external artificial pancreas. The system is composed of 3 components: continuous glucose sensor (to constantly read blood glucose changes), infusion pumps (to provide insulin with or without glucagon the main hormone to raise blood glucose) and an intelligent dosing software that modify pump infusions based on the sensor readings. Our 9 ongoing or completed trials have shown that the artificial pancreas improves both high and low blood glucose values, for example a 4 to 8-fold hypoglycemic risk reduction. Specifically, the aim of this study is to test the efficacy of the system to prevent exercise induce hypoglycemia in adults with T1D.
Two types of exercise will be tested continuous with moderate intensity and interval with high intensity. The metabolism of glucose by the body will also be studied during the different interventions. The results will help to improve the performance of the artificial pancreas and to guide long term trials under free living conditions planned to start in the next year.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Taleb, Nadine M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~